We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M Turnover 20%
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
+57.24%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$245M
AUM Growth
+$41.7M
Cap. Flow
-$37.5M
Cap. Flow %
-15.29%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
1
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.8 years
Top 20 Avg Time Held
2.8 years

Top Buys

No buys this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DYN icon
1
Dyne Therapeutics
DYN
$2.86B
$98M 39.97%
3,451,303
-1,500,000
-30% -$33.9M
2020 Q3
14 quarters
TRDA icon
2
Entrada Therapeutics
TRDA
$180M
$62.7M 25.58%
4,425,784
– –
2021 Q4
9 quarters
ITOS icon
3
DELISTED
iTeos Therapeutics
ITOS
$37.4M 15.24%
2,738,785
– –
2020 Q3
14 quarters
HOWL icon
4
Werewolf Therapeutics
HOWL
$49.1M
$27.8M 11.32%
4,284,172
– –
2021 Q2
11 quarters
RPTX icon
5
DELISTED
Repare Therapeutics
RPTX
$10.6M 4.31%
2,242,636
– –
2020 Q2
15 quarters
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
$8.78M 3.58%
5,555,461
– –
2023 Q2
3 quarters
HARP
7
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
– –
-313,136
Closed -$3.56M –

Similar funds

MPM Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, MPM Asset Management held 7 positions worth $245M, up 20% from $204M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MPM Asset Management withdrew a net $37.5M in Q1 2024, closing 1 position and reducing 1 holding. Its most notable exit was Harpoon Therapeutics, Inc. Common Stock, an estimated $3.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management's biggest Q1 2024 reduction was Dyne Therapeutics, cutting an estimated $33.9M.
  • MPM Asset Management fully exited Harpoon Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $3.56M.
  • MPM Asset Management's ten largest holdings make up 100% of its $245M portfolio in Q1 2024.
  • MPM Asset Management opened 0 new positions and closed 1 in Q1 2024.
  • MPM Asset Management's portfolio value rose 20% quarter-over-quarter to $245M.

Based on MPM Asset Management's 13F filing for Q1 2024, filed 15 May 2024.